Nitric oxide

From Wikipedia, the free encyclopedia

Jump to: navigation, search
Nitric oxide
Nitric oxide
Nitric oxide
Identifiers
CAS number [10102-43-9]
PubChem 3815
UN number 1660
DrugBank DB00435
KEGG C00533
ChEBI 16480
RTECS number QX0525000
ATC code R07AX01
InChI
Properties
Molecular formula NO
Molar mass 30.006 g/mol
Appearance colourless gas
Density 1.3 g/cm3 (liquid)
1.34 g/l (gas)
Melting point

−163.6 °C (109.6 K)

Boiling point

−151.7 °C (121.4 K)

Solubility in water 7.4 ml/100 ml (STP)
Structure
Molecular shape linear, C∞v
Thermochemistry
Std enthalpy of
formation
ΔfHo298
+90.29 kJ/mol
Standard molar
entropy
So298
210.76 J K−1 mol−1
Pharmacology
Bioavailability good
Routes of
administration
Inhalation
Metabolism via pulmonary capillary bed
Elimination
half-life
2–6 seconds
Hazards
MSDS External MSDS
EU Index Not listed
Main hazards Toxic
NFPA 704
0
3
0
OX
Flash point Non-flammable
Related compounds
Related nitrogen oxides Nitrous oxide
Dinitrogen trioxide
Nitrogen dioxide
Dinitrogen tetroxide
Dinitrogen pentoxide
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)

Infobox references

Nitric oxide or nitrogen monoxide is a chemical compound with chemical formula NO. This gas is an important signaling molecule in the body of mammals, including humans, and is an extremely important intermediate in the chemical industry. It is also an air pollutant produced by cigarette smoke, automobile engines and power plants.

NO is an important messenger molecule involved in many physiological and pathological processes within the mammalian body both beneficial and detrimental.[1] Appropriate levels of NO production are important in protecting an organ such as the liver from ischemic damage. However sustained levels of NO production result in direct tissue toxicity and contribute to the vascular collapse associated with septic shock, whereas chronic expression of NO is associated with various carcinomas and inflammatory conditions including juvenile diabetes, multiple sclerosis, arthritis and ulcerative colitis. [2]

Nitric oxide should not be confused with nitrous oxide (N2O), a general anaesthetic and greenhouse gas, or with nitrogen dioxide (NO2) which is another air pollutant. The nitric oxide molecule is a free radical, which is relevant to understanding its high reactivity.

Despite being a startlingly simple molecule, NO is a fundamental player in the fields of neuroscience, physiology, and immunology, and was proclaimed “Molecule of the Year” in 1992[3]

Contents

[edit] Reactions

2NO + O2 → 2NO2
This conversion has been speculated as occurring via the ONOONO intermediate. In water, NO reacts with oxygen and water to form HNO2 or nitrous acid. The reaction is thought to proceed via the following stoichiometry:
4 NO + O2 + 2 H2O → 4 HNO2
  • NO will react with fluorine, chlorine, and bromine to form the XNO species, known as the nitrosyl halides, such as nitrosyl chloride. Nitrosyl iodide can form but is an extremely short lived species and tends to reform I2.
2NO + Cl2 → 2NOCl
  • Nitroxyl (HNO) is the reduced form of nitric oxide.
Traube reaction
This is a very old reaction (1898) but of interest today in NO prodrug research. Nitric oxide can also react directly with sodium methoxide, forming sodium formate and nitrous oxide [5].

[edit] Preparation

  • Commercially, NO is produced by the oxidation of ammonia at 750°C to 900°C (normally at 850°C) in the presence of platinum as catalyst:
4NH3 + 5O2 → 4NO + 6H2O
The uncatalyzed endothermic reaction of O2 and N2 which is performed at high temperature (>2000°C) with lightning has not been developed into a practical commercial synthesis (see Birkeland-Eyde process):
N2 + O2 → 2NO
  • In the laboratory, it is conveniently generated by reduction of nitric acid:
8HNO3 + 3Cu → 3Cu(NO3)2 + 4H2O + 2NO
  • or by the reduction of nitrous acid:
2 NaNO2 + 2 NaI + 2 H2SO4 → I2 + 4 NaHSO4 + 2 NO
2 NaNO2 + 2 FeSO4 + 3 H2SO4 → Fe2(SO4)3 + 2 NaHSO4 + 2 H2O + 2 NO
3 KNO2(l) + KNO3 (l) + Cr2O3(s) → 2 K2CrO4(s) + 4 NO (g)
The iron(II) sulfate route is simple and has been used in undergraduate laboratory experiments.
  • So-called NONOate compounds are also used for NO generation.

[edit] Coordination Chemistry

NO forms complexes with all transition metals to give complexes called metal nitrosyls. The most common bonding mode of NO is the terminal linear type (M-NO). The angle of the M-N-O group can vary from 160-180° but are still termed as "linear". In this case the NO group is formally considered a 3-electron donor. In the case of a bent M-N-O conformation the NO group can be considered a one electron donor.[6]. Alternatively, one can view such complexes as derived from NO+, which is isoelectronic with CO.

Nitric oxide can serve as a one-electron pseudohalide. In such complexes, the M-N-O group is characterized by an angle between 120-140°.

The NO group can also bridge between metal centers through the nitrogen atom in a variety of geometries.

[edit] Measurement of nitric oxide concentration

The concentration of nitric oxide can be determined using a simple chemiluminescent reaction involving ozone:[7] A sample containing nitric oxide is mixed with a large quantity of ozone. The nitric oxide reacts with the ozone to produce oxygen and nitrogen dioxide. This reaction also produces light (chemiluminescence), which can be measured with a photodetector. The amount of light produced is proportional to the amount of nitric oxide in the sample.

NO + O3 → NO2 + O2 + light

Other methods of testing include electroanalysis(amperometric approach), where NO reacts with an electrode to induce a current or voltage change. The detection of NO radicals in biological tissues is particularly difficult due to the short lifetime and concentration of these radicals in tissues. One of the few practical methods is spin trapping of nitric oxide with iron-dithiocarbamate complexes and subsequent detection of the mono-nitrosyl-iron complex with Electron Paramagnetic Resonance (EPR).[8][9]

A group of fluorescent dye indicators exist that are also available in acetylated form for intracellular measurements. The most common compound is 4,5-diaminofluorescein (DAF-2).[3]

[edit] Production environmental effects

From a thermodynamic perspective, NO is unstable with respect to O2 and N2, although this conversion is very slow at ambient temperatures in the absence of a catalyst. Because the heat of formation of NO is endothermic, its synthesis from molecular nitrogen and oxygen requires elevated temperatures, >1000°C. A major natural source is lightning. The use of internal combustion engines has drastically increased the presence of nitric oxide in the environment. One purpose of catalytic converters in cars is to minimize NO emission by catalytic reversion to O2 and N2.

Nitric oxide in the air may convert to nitric acid, which has been implicated in acid rain. Furthermore, both NO and NO2 participate in ozone layer depletion. Nitric oxide is a small highly diffusible gas and a ubiquitous bioactive molecule.


[edit] Technical applications

Although NO has relatively few direct uses, it is produced on a massive scale as an intermediate in the Ostwald process for the synthesis of nitric acid from ammonia. In 2005, the US alone produced 6M metric tons of nitric acid.[10] It finds use in the semiconductor industry for various processes. In one of its applications it is used along with nitrous oxide to form oxynitride gates in CMOS devices.

[edit] Miscellaneous applications

Nitric oxide can be used for detecting surface radicals on polymers. Quenching of surface radicals with nitric oxide results in incorporation of nitrogen, which can be quantified by means of X-ray photoelectron spectroscopy.[citation needed]

[edit] Biological functions

NO is one of the few gaseous signaling molecules known. It is a key vertebrate biological messenger, playing a role in a variety of biological processes. Nitric oxide, known as the 'endothelium-derived relaxing factor', or 'EDRF', is biosynthesised endogenously from arginine and oxygen by various nitric oxide synthase (NOS) enzymes and by reduction of inorganic nitrate. The endothelium (inner lining) of blood vessels use nitric oxide to signal the surrounding smooth muscle to relax, thus resulting in vasodilation and increasing blood flow. Nitric oxide is highly reactive (having a lifetime of a few seconds), yet diffuses freely across membranes. These attributes make nitric oxide ideal for a transient paracrine (between adjacent cells) and autocrine (within a single cell) signaling molecule.[11] The production of nitric oxide is elevated in populations living at high-altitudes, which helps these people avoid hypoxia by aiding in pulmonary vasculature vasodilation. Effects include vasodilatation, neurotransmission (see Gasotransmitters), modulation of the hair cycle, production of reactive nitrogen intermediates and penile erections (through its ability to vasodilate). Nitroglycerin and amyl nitrite serve as vasodilators because they are converted to nitric oxide in the body. Sildenafil, popularly known by the trade name Viagra, stimulates erections primarily by enhancing signaling through the nitric oxide pathway in the penis.

Nitric oxide (NO) contributes to vessel homeostasis by inhibiting vascular smooth muscle contraction and growth, platelet aggregation, and leukocyte adhesion to the endothelium. Humans with atherosclerosis, diabetes or hypertension often show impaired NO pathways.[12] A high-salt intake was demonstrated to attenuate NO production, although bioavailability remains unregulated.[13]

Nitric oxide is also generated by phagocytes (monocytes, macrophages, and neutrophils) as part of the human immune response. Phagocytes are armed with inducible nitric oxide synthase (iNOS) which is activated by interferon-gamma (IFN-γ) as a single signal or by tumor necrosis factor (TNF) along with a second signal. [14] Conversely, transforming growth factor-beta (TGF-β) provides a strong inhibitory signal to iNOS whereas interleukin-4 (IL-4) and IL-10 provide weak inhibitory signals. In this way the immune system may regulate the armamentarium of phagocytes that play a role in inflammation and immune responses. Nitric oxide secreted as an immune response is as free radicals and is toxic to bacteria; the mechanism for this include DNA damage and degradation of iron sulfur centers into iron ions and iron-nitrosyl compounds. [15] [16] [17] In response, however, many bacterial pathogens have evolved mechanisms for nitric oxide resistance.[18] Because nitric oxide might serve as an inflammometer in conditions like asthma, there has been increasing interest in the use of exhaled nitric oxide as a breath test in diseases with airway inflammation.

Nitric oxide can contribute to reperfusion injury when an excessive amount produced during reperfusion (following a period of ischemia) reacts with superoxide to produce the damaging oxidant peroxynitrite. In contrast, inhaled nitric oxide has been shown to help survival and recovery from paraquat poisoning, which produces lung tissue damaging superoxide and hinders NOS metabolism.

In plants, nitric oxide can be produced by any of four routes: (i)L-arginine-dependent nitric oxide synthase [19], [20],[21],(although the existence animal NOS homologs in plants is debated)[22],(ii) by plasma membrane-bound nitrate reductase, (iii) by mitochondrial electron transport chain, or (iv) by non-enzymatic reactions. It is a signaling molecule, acts mainly against oxidative stress and also plays a role in plant pathogen interactions. Treating cut flowers and other plants with nitric oxide has been shown to lengthen the time before wilting.[23]

A biologically important reaction of nitric oxide is S-nitrosylation, the conversion of thiol groups, including cysteine residues in proteins, to form S-nitrosothiols (RSNOs). S-Nitrosylation is a mechanism for dynamic, post-translational regulation of most or all major classes of protein.

[edit] Mechanism of action

There are several mechanisms by which NO has been demonstrated to affect the biology of living cells. These include oxidation of iron containing proteins such as ribonucleotide reductase and aconitase, activation of the soluble guanylate cyclase, ADP ribosylation of proteins, protein sulphhydryl group nitrosylation, and iron regulatory factor activation. [24] NO has been demonstrated to activate NF-κB in peripheral blood mononuclear cells, an important transcription factor in iNOS gene expression in response to inflammation.[25] It was found that NO acts through the stimulation of the soluble guanylate cyclase which is a heterodimeric enzyme with subsequent formation of cyclic GMP. Cyclic GMP activates protein kinase G, which caused phosphorylation (and therefore inactivation) of myosin light-chain kinase and leads ultimately to the dephosphorylation of the myosin light chain, causing smooth muscle relaxation. [26]

[edit] Use in pediatric intensive care

Nitric oxide/oxygen blends are used in critical care to promote capillary and pulmonary dilation to treat primary pulmonary hypertension in neonatal patients[27][28] post meconium aspiration and related to birth defects. These are often a last-resort gas mixture before the use of ECMO. Nitric oxide therapy has the potential to significantly increase the quality of life and in some cases save the lives of infants at risk for pulmonary vascular disease.[29]

[edit] Nutraceutical marketing

GNC has begun to sell an oral "nitric oxide" product targeted for bodybuilders, with the claim that it dramatically increases muscle growth. The claim is grounded in an understanding of NO as being a vasodilator, and when taken prior to and after workouts, it enables muscles to receive more blood and therefore, more oxygen and nutrients. This is critical to maximal muscle exertion during training and recovery afterward. However, there are currently no valid studies supporting the hypothesis that orally ingested NO actually will cause vasodilation; additionally, while users of some supplements have claimed to experience results, these results are generally attributable to ingredients besides NO itself (proteins, creatine etc).

[edit] References

  1. ^ Hou Y.C., Janczuk A. and Wang P.G. (1999): Current trends in the development of nitric oxide donors. Curr. Pharm. Des. June, 5 (6): 417- 471
  2. ^ Tylor B.S., Kion Y.M., Wang Q.I., Sharpio R.A., Billiar T.R. and Geller D.A. (1997): Nitric oxide down regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch. Surg. 1, (32). Nov.; 1177-1182.
  3. ^ a b Elizabeth Culotta and Daniel E. Koshland Jr (December 1992). "NO news is good news. (nitric oxide; includes information about other significant advances & discoveries of 1992) (Molecule of the Year)". Science 258 (5090): 1862–1864. doi:10.1126/science.1361684. PMID 1361684. 
  4. ^ Ueber Synthesen stickstoffhaltiger Verbindungen mit Hülfe des Stickoxyds Justus Liebig's Annalen der Chemie Volume 300, Issue 1, Date: 1898, Pages: 81-128 Wilhelm Traube doi:10.1002/jlac.18983000108
  5. ^ Nitric Oxide Reacts with Methoxide Frank DeRosa, Larry K. Keefer, and Joseph A. Hrabie J. Org. Chem. 2008, 73, 1139-1142 doi:10.1021/jo7020423
  6. ^ Catherine E. Housecroft and Alan G. Sharpe: "Inorganic Chemistry", page 570. Pearson Education Limited 2001, 2005
  7. ^ Fontijn, A., A. J. Sabadell and R. J. Ronco (1970). "Homogeneous chemiluminescent measurement of nitric oxide with ozone." Analytical Chemistry 42(6): 575-579.
  8. ^ Vanin A. F.; Huisman A.; van Faassen E.E.; Methods in Enzymology vol 359 (2002) 27 - 42
  9. ^ Nagano T.; Yoshimura T.; "Bioimaging of nitric oxide", Chemical Reviews vol 102 (2002) 1235 - 1269.
  10. ^ “Production: Growth is the Norm” Chemical and Engineering News, July 1 0, 2006, p. 59.
  11. ^ Stryer, Lubert (1995). Biochemistry, 4th Edition. W.H. Freeman and Company. pp. 732. ISBN 0-7167-2009-4. 
  12. ^ Dessy, C.; Ferron, O. (September 2004). "Pathophysiological Roles of Nitric Oxide: In the Heart and the Coronary Vasculature". Current Medical Chemistry - Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Bentham Science Publishers Ltd.) 3 (3): 207-216. ISSN 1871-5230. 
  13. ^ http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ProduktNr=223997&Ausgabe=228460&ArtikelNr=63555
  14. ^ Gorczyniski and Stanely, Clinical Immunology. Landes Bioscience; Austin, TX. ISBN 1570596255
  15. ^ Nitric oxide synthesis and TNF-alpha secretion in RAW 264.7 macrophages: mode of action of. 
  16. ^ Threshold Effects of Nitric Oxide-Induced Toxicity and Cellular Responses in Wild-Type and p53-Null Human Lymphoblastoid Cells
  17. ^ Hibbs JB, Jr., Taintor RR, Vavrin Z, Rachlin EM (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157:87-94.
  18. ^ C. A. Janeway, et al. (2005). Immunobiology: the immune system in health and disease (6th ed. ed.). New York: Garland Science. ISBN 0-8153-4101-6. 
  19. ^ Corpas et al. (2004). "Cellular and subcellular localization of endogenous nitric oxide in young and senescent pea plants". Plant Physiology 136 (1): 2722–33. doi:10.1104/pp.104.042812. PMID 15347796. 
  20. ^ Corpas et al. (2006). "Constitutive arginine-dependent nitric oxide synthase activity in different organs of pea seedlings during plant development". Planta 224 (2): 246–54. doi:10.1007/s00425-005-0205-9. 
  21. ^ Valderrama et al. (2007). "Nitrosative stress in plants". FEBS Lett 581 (3): 453–61. doi:10.1016/j.febslet.2007.01.006. 
  22. ^ Corpas et al. (2004). "Enzymatic sources of nitric oxide in plant cells – beyond one protein–one function". New Phytologist 162: 246–7. doi:10.1111/j.1469-8137.2004.01058.x. 
  23. ^ Judy Siegel-Itzkovich. Viagra makes flowers stand up straight. Student BMJ, September 1999.
  24. ^ Shami P.J., Moore J.O., Cockerman J.P., Halhorn W.J., Misukonis M.A., and Weinberg J.B. (1995): Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukaemia cells. Leukaemia Research; 19(8): 527 - 534.
  25. ^ Kaibori M., Sakitani K., Oda M., Kamiyama Y., Masu Y. and Okumura T.(1999). Immunosuppressant FK56 inhibits iNOS gene expression at a step of NF-Kappa B activation in rat hepatocytes. J. Hepatol. Jan; 30 (6): 1138-1145.
  26. ^ 'cGMP-Dependent Protein Kinase I and Smooth Muscle Relaxation: A Tale of Two Isoforms', Howard K. Surks (Circ. Res. 2007;101;1078-1080)
  27. ^ Finer NN, Barrington KJ (2006). "Nitric oxide for respiratory failure in infants born at or near term". Cochrane Database Syst Rev (4): CD000399. doi:10.1002/14651858.CD000399.pub2. PMID 17054129. 
  28. ^ Chotigeat U, Khorana M, Kanjanapattanakul W (February 2007). "Inhaled nitric oxide in newborns with severe hypoxic respiratory failure". J Med Assoc Thai 90 (2): 266–71. PMID 17375630. 
  29. ^ Hayward C.S., Kelly R.P. and Macdonald P.S. (1999): Inhaled nitric oxide in cardiology practice. Cadio. Vasc. Res. Aug.; 15, 43 (3): 628 - 638.

[edit] Further reading

  • Butler A. and Nicholson R.; " Life, death and NO." Cambridge 2003. ISBN-13: 978-0-85404-686-7.
  • Corpas FJ et al “Constitutive arginine-dependent nitric oxide synthase activity in different organs of pea seedlings during plant development” Planta 2006 224(2):246-54.
  • Corpas FJ, del Río LA, Barroso JB. "Need of biomarkers of nitrosative stress in plants" Trends Plant Sci. 2007 12(10):436-8.
  • van Faassen, E. E.; Vanin, A. F. (eds); " Radicals for life: The various forms of Nitric Oxide." Elsevier, Amsterdam 2007. ISBN-13: 978-0-444-52236-8.
  • F.A. Cotton, G. Wilkinson, C.A. Murillo, M. Bochmann; Advanced Inorganic Chemistry, 6th ed. Wiley-Interscience, New York, 1999.
  • K.J. Gupta , M. Stoimenova, and W. M. Kaiser "In higher plants, only root mitochondria, but not leaf mitochondria reduce nitrite to NO, in vitro and in situ" Journal of Experimental Botany 2005 56(420):2601-2609.
  • E.Planchet, K.J. Gupta, M .Sonada & W.M.Kaiser (2005) "Nitric oxide emission from tobacco leaves and cell suspensions: rate limiting factors and evidence for the involvement of mitochondrial electron transport"The Plant Journal 41 (5), 732-743.
  • Stöhr, C.; Stremlau, S. "Formation and possible roles of nitric oxide in plant roots" Journal of Experimental Botany 2006 57(3):463-470.
  • Pacher, P.; Beckman, J. S.; Liaudet, L.; “Nitric Oxide and Peroxynitrite: in Health and disease” Physiological Reviews 2007, volume 87(1), page 315-424. PMID 17237348.
  • Valderrama et al. "Nitrosative stress in plants" FEBS Lett. 2007 581(3):453-61.

[edit] External links

Personal tools